Tiedemann Trust’s Novartis NVS Stock Holding History

Tiedemann Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-6,696	Closed	-$424K	–	102
2013 Q2	$424K	Buy	+6,696	New	+$436K	0.07%	79

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Tiedemann Trust's NVS Position: Q3 2013 in Review

Tiedemann Trust sold out of Novartis (NVS) in Q3 2013, closing a stake of 6,696 shares — an estimated $424K sold.

Tiedemann Trust first reported a position in NVS in Q2 2013 and held it in 1 quarter. The position peaked at $424K in Q2 2013. 761 funds tracked by Wall St. Rank hold NVS as of Q3 2013.

Tiedemann Trust reported no remaining Novartis position as of Q3 2013 after selling out during the quarter.
Tiedemann Trust sold 6,696 Novartis shares in Q3 2013, an estimated $424K.
Tiedemann Trust first reported a position in Novartis in Q2 2013 and held it in 1 quarter.
Tiedemann Trust's Novartis position peaked at $424K in Q2 2013.
761 funds tracked by Wall St. Rank held Novartis as of Q3 2013.

Based on Tiedemann Trust's 13F filing for Q3 2013, filed 12 Nov 2013.